Investing.com - BIO-Key (NASDAQ: BKYI) reported first quarter EPS of $-0.060, $0.09 better than the analyst estimate of $-0.150. Revenue for the quarter came in at $3.08M versus the consensus estimate of $3M.
BIO-Key's stock price closed at $0.650. It is down -19.730% in the last 3 months and down -61.930% in the last 12 months.
BIO-Key saw positive EPS revisions and negative EPS revisions in the last 90 days. See BIO-Key's stock price’s past reactions to earnings here.
According to InvestingPro, BIO-Key's Financial Health score is "fair performance".
Check out BIO-Key's recent earnings performance, and BIO-Key's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar